This matters as a new cornerstone therapy in type 2 diabetes (T2DM), glucagon-like peptide-1 receptor agonists (GLP-1), are entering broader use, necessitating a deeper dive into how this treatment interacts, directly or indirectly, with pathways influenced by sex hormones
Results Disclaimer: Individual results vary significantly based on factors including age, baseline health, starting weight, adherence to treatment, lifestyle factors, genetics, and current medications
Healthcare professionals prescribing GLP-1 medicines should provide balanced information about theoretical risks based on animal studies whilst emphasising that human evidence is reassuring
TABLE 1 Properties of different isoforms of the catalytic alpha subunit of Na,K-ATPase
When to Consider Medical Support: Clinical Indicators and Provider Guidance Not all individuals achieve adequate weight loss through lifestyle modification alone